MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$110,745K
Accounts receivable, net
$33,082K
Inventories
$16,464K
Prepaid expenses and
other current assets
$14,672K
Marketable securities
$9,711K
Restricted cash
$1,350K
Property and equipment,
gross
$5,224K
Total current assets
$186,024K
Right-of-use assets,
operating and finance...
$8,456K
Other non-current
assets
$5,161K
Property and equipment,
net
$637K
Restricted deposit
$177K
Less accumulated
depreciation and...
$4,587K
Total assets
$200,455K
Accumulated deficit
-$959,716K
Total liabilities and
shareholders' deficit
$200,455K
Total shareholders'
deficit
-$105,474K
Additional paid-in capital
$854,090K
Ordinary shares, nis 0.01
par value...
$133K
Accumulated other
comprehensive income
$19K
Total liabilities
$305,929K
Prepaid forward
obligation
$127,276K
Long-term debt
$122,210K
Total current
liabilities
$46,418K
Lease, liabilities,
noncurrent
$6,122K
Uncertain tax positions
liability
$3,903K
Accounts payable and
accrued expenses
$27,717K
Employee related accrued
expenses
$13,516K
Other liabilities,
current
$5,185K
Back
Back
Balance Sheet
source: myfinsight.com
UroGen Pharma Ltd. (URGN)
UroGen Pharma Ltd. (URGN)